中国医药：子公司获得化学原料药上市申请批准通知书

Group 1 - The core point of the article is that China Medical announced the approval of a new drug application for fumaric acid volnorasone by its wholly-owned subsidiary Tianfang Pharmaceutical [1] Group 2 - Tianfang Pharmaceutical received the approval notice from the National Medical Products Administration for the chemical raw material drug [1]